Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis

Bibliography

• Patani N, Mokbel K. Herceptin and breast cancer: an overview for surgeons. Surg Oncol 2010;19:e11-21
   PubMed Web of Science ®Google Scholar
• Yamashiro H, Toi M. Molecular targeted therapy for breast cancer treatment, challenge to cure. Nippon Rinsho 2010;68:1854-8
   PubMedGoogle Scholar
• Zhukov NV, Tjulandin SA. Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochemistry (Mosc) 2008;73:605-18
   PubMed Web of Science ®Google Scholar
• Desai AG, Qazi GN, Ganju RK, Medicinal plants and cancer chemoprevention. Curr Drug Metab 2008;9:581-91
   PubMed Web of Science ®Google Scholar
• Efferth T. Cancer therapy with natural products and medicinal plants. Planta Med 2010;76:1035-6
   PubMed Web of Science ®Google Scholar
• Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007;13:353-61
   PubMed Web of Science ®Google Scholar
• Zhu M, Wong PY, Li RC. Influence of Sanguisorba officinalis, a mineral-rich plant drug, on the pharmacokinetics of ciprofloxacin in the rat. J Antimicrob Chemother 1999;44:125-8
   PubMed Web of Science ®Google Scholar
• Jiang L, Liao HX, Jin HH, Wang W. Clinical Observation of diyushengbai tablet and G-CSF on cure arrest of bone marrow after chemotherapy of gynaecology tumour. Chin J Basic Med Tradit Chin Med 2010;16:1079-80
   Google Scholar
• Lee NH, Lee MY, Lee JA, Anti-asthmatic effect of Sanguisorba officinalis L. and potential role of heme oxygenase-1 in an ovalbumin-induced murine asthma model. Int J Mol Med 2010;26:201-8
   PubMed Web of Science ®Google Scholar
• Kim TG, Kang SY, Jung KK, Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus. Phytother Res 2001;15:718-20
   PubMed Web of Science ®Google Scholar
• Liu X, Cui Y, Yu Q, Yu B. Triterpenoids from Sanguisorba officinalis. Phytochemistry 2005;66:1671-9
   PubMed Web of Science ®Google Scholar
• Bastow KF, Bori ID, Fukushima Y, Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin from Sanguisorba officinalis. Planta Med 1993;59:240-5
   PubMed Web of Science ®Google Scholar
• Wang ZY, Wang DM, Loo TY, Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint. J Ethnopharmacol 2011;133:751-8
   Google Scholar
• Efferth T. Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products. Planta Med 2010;76:1143-54
   PubMed Web of Science ®Google Scholar
• Youns M, Hoheisel JD, Efferth T. Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. Curr Drug Discov Technol 2010;7:37-45
   PubMedGoogle Scholar
• Chen HM, Wu YC, Chia YC, Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett 2009;286:161-71
   PubMed Web of Science ®Google Scholar
• Edderkaoui M, Odinokova L, Ohno I, Ellagic acid induces apoptosis through inhibition of nuclear factor kappaB in pancreatic cancer cells. World J Gastroenterol 2008;14:3672-80
   PubMed Web of Science ®Google Scholar
• Cerda B, Tomas-Barberan FA, Espin JC. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem 2005;53:227-35
   PubMed Web of Science ®Google Scholar
• Giftson JS, Jayanthi S, Nalini N. Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 2010;28:251-9
   PubMed Web of Science ®Google Scholar
• Khanduja KL, Gandhi RK, Pathania V, Syal N. Prevention of N-nitrosodiethyla mine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 1999;37:313-18
   PubMed Web of Science ®Google Scholar
• Kang JX, Liu J, Wang J, The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells. Carcinogenesis 2005;26:1934-9
   PubMed Web of Science ®Google Scholar
• Ebos JM, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 2011;8:210-21
   PubMed Web of Science ®Google Scholar
• Pirker R. Bevacizumab in lung cancer: hurdles in clinical development. Lancet Oncol 2010;11:703-4
   PubMed Web of Science ®Google Scholar
• Je Y, Schutz FA, Choueiri TK. Risk of bleeding with vascular endothelial gorwth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncol 2009;10:967-74
   PubMed Web of Science ®Google Scholar
• Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 2010;60:222-43
   PubMed Web of Science ®Google Scholar
• Grothey A, Galanis E. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 2009;6:507-18
   PubMed Web of Science ®Google Scholar